We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Micrus Endovascular To Market Stretch-Resistant Microcoils in Japan

By HospiMedica staff writers
Posted on 25 Dec 2007
Micrus Endovascular Corporation (San Jose, CA, USA) has announced receipt of Shonin (direct registration) approval to market its full line of stretch-resistant microcoils for the endovascular treatment of cerebral aneurysms in Japan. More...


The Micrus MicroCoil System employs a frame and fill technique, whereby the aneurysm is first framed by deploying a spherically shaped microcoil that assumes an anatomically compliant frame within the aneurysm's fragile perimeter. A MicroSphere spherical coil is used to frame the aneurysm, and is placed and deployed within the aneurysm by means of a low temperature resistive heating (RH) delivery system. In aneurysms with greater than 4 mm diameter, a second spherical coil may be deployed to strengthen the frame. Subsequent HeliPaq helical coils are then used to fill the aneurysm until it is completely occluded from the cerebral circulation. Each microcoil detachment is accomplished with the push of a button. A selection of sizes is available to enable treatment of a range of aneurysm sizes.

Sales of Micrus stretch-resistant microcoils will be managed by Goodman Co. (Nagoya, Japan), Micrus Endovascular's exclusive distributor in the Japanese market, and will also include the Cashmere, Presidio, HeliPaq, and UltiPaq stretch-resistant embolic coils.

"We are very pleased to expand our product offering in Japan where we have already developed a significant presence. Our Micrus bare platinum microcoils are currently used in approximately half of all embolic procedures and, with the approval of our stretch-resistant microcoils, we now have the opportunity to build upon this foundation,” said John Kilcoyne, Micrus Endovascular Chairman and CEO. "Additionally, we continue to work with regulatory officials in Japan to gain approval for our Cerecyte bioactive microcoils.


Related Links:
Micrus Endovascular Corporation
Goodman

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.